Your browser doesn't support javascript.
loading
The genetic landscape of pancreatic head ductal adenocarcinoma in China and prognosis stratification.
Yang, Yefan; Ding, Ying; Gong, Yuxi; Zhao, Sha; Li, Mingna; Li, Xiao; Song, Guoxin; Zhai, Boya; Liu, Jin; Shao, Yang; Zhu, Liuqing; Pang, Jiaohui; Ma, Yutong; Ou, Qiuxiang; Wu, Xue; Zhang, Zhihong.
Afiliación
  • Yang Y; Department of Pathology, the First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, 210029, Jiangsu Province, China.
  • Ding Y; Department of Pathology, the First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, 210029, Jiangsu Province, China.
  • Gong Y; Department of Pathology, the First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, 210029, Jiangsu Province, China.
  • Zhao S; Department of Pathology, the First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, 210029, Jiangsu Province, China.
  • Li M; Department of Pathology, the First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, 210029, Jiangsu Province, China.
  • Li X; Department of Pathology, the First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, 210029, Jiangsu Province, China.
  • Song G; Department of Pathology, the First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, 210029, Jiangsu Province, China.
  • Zhai B; Department of Pathology, the First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, 210029, Jiangsu Province, China.
  • Liu J; Clinical Medicine Research Institution, the First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, 210029, Jiangsu Province, China.
  • Shao Y; Nanjing Geneseeq Technology Inc, Nanjing, 210032, Jiangsu Province, China.
  • Zhu L; Nanjing Geneseeq Technology Inc, Nanjing, 210032, Jiangsu Province, China.
  • Pang J; Nanjing Geneseeq Technology Inc, Nanjing, 210032, Jiangsu Province, China.
  • Ma Y; Nanjing Geneseeq Technology Inc, Nanjing, 210032, Jiangsu Province, China.
  • Ou Q; Nanjing Geneseeq Technology Inc, Nanjing, 210032, Jiangsu Province, China.
  • Wu X; Nanjing Geneseeq Technology Inc, Nanjing, 210032, Jiangsu Province, China.
  • Zhang Z; Department of Pathology, the First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, 210029, Jiangsu Province, China. zhangzh@njmu.edu.cn.
BMC Cancer ; 22(1): 186, 2022 Feb 18.
Article en En | MEDLINE | ID: mdl-35180847
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Proteína p53 Supresora de Tumor / Proteínas Proto-Oncogénicas p21(ras) / Inhibidor p16 de la Quinasa Dependiente de Ciclina / Carcinoma Ductal Pancreático / Proteína Smad4 Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Proteína p53 Supresora de Tumor / Proteínas Proto-Oncogénicas p21(ras) / Inhibidor p16 de la Quinasa Dependiente de Ciclina / Carcinoma Ductal Pancreático / Proteína Smad4 Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: China